Fig. 4: Country-wise contribution to vaccine-avertable deaths from RR-TB.
From: Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine
As for Fig. 2, the area of each square here is proportional to the median estimate from n = 200 posterior samples, for the absolute number of avertable rifampicin-resistant tuberculosis (RR-TB) deaths by a post-exposure, M72-like vaccine, between 2020 and 2035. Panel a shows deaths averted by a vaccine alone, while panel b shows deaths averted by a combination of a vaccine and measures to improve the management of RR-TB (both relative to a scenario of no vaccine, and no improvement in RR-TB, i.e. status quo). Countries are denoted by their ISO alpha-3 codes and their corresponding full names are listed in Table 1. Colours for each country are only for the purpose of display, and do not designate any quantitative scale.
